NRC Health
NRC | NASDAQ
$23.83
+$0.34 (+1.45%)
At close: Oct 30, 2026, 4:00 PM ET
$24.00
+$0.17 (+0.71%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Company Profile
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
Key Executives
| Name | Position |
|---|---|
| Trent Green | CEO, Principal Executive Officer & Director |
| Andrew Monnich | EVP & Chief Corporate Development Officer |
| David Burik | Executive Vice President of Strategic Insights |
| Helen L. Hrdy | EVP & COO |
| Jason R. Rau | Executive Vice President of Sales |
| Jennifer Baron | Chief Experience Officer |
| Jordan N. Freeman | Chief Accounting Officer |
| Michael D. Hays | Founder & Chairman |
| Shane R. Harrison | Executive VP, CFO, Treasurer & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 11, 2026 | 8-K | Current Report |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Jul 28, 2026 | 8-K | Current Report |
| Jun 29, 2026 | 8-K | Current Report |
| Jun 25, 2026 | 4 | Filing |
| Jun 25, 2026 | 4 | Filing |
| Jun 25, 2026 | 4 | Filing |
| Jun 25, 2026 | 4 | Filing |
| Jun 25, 2026 | 4 | Filing |
NRC Health
| Country | United States |
| IPO Date | May 23, 2013 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 357 |
| CEO | Trent Green |
Contact Details
1245 Q Street Lincoln,
Nebraska 68508 United States
Stock Details
| Ticker Symbol | NRC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000070487 |
| CUSIP Number | 637372202 |
| ISIN Number | US6373722023 |
| SIC Code | 8731 |
Add to Watchlist
Select watchlists to add or remove NRC